Future Of Personalized Medicine for Oncology Summit

#FPMS2024

Date - 15th April, 2024
Time - 9:00 AM PDT
Venue - San Francisco, United States

Register As a Delegate Become a Sponsor Request Brochure

About The Future Of Personalized Medicine for Oncology Summit


The Future of Personalized Medicine for Oncology, the one-day summit is a conference where leading experts in oncology gather to discuss the latest advances and future directions in personalized medicine for cancer treatment. Personalized medicine is a medical approach that tailors treatment to an individual patient's specific genetic, environmental, and lifestyle factors to improve patient outcomes and reduce side effects. The summit will cover topics such as precision medicine, biomarkers, genomic profiling, immunotherapy, and other advanced technologies and approaches in oncology. Speakers will share experiences and insights on how personalized medicine is transforming cancer care and improving patient outcomes. All in all, "The Future of Personalized Medicine at the Oncology Virtual Summit" will be an exciting and informative event for anyone interested in the future of cancer treatment and the role of personalized medicine in transforming the field.

Precision Medicine and Its Impact on Cancer Treatment

Precision medicine is a novel approach to cancer treatment that tailors treatment to the individual patient's specific genetic, environmental, and lifestyle factors. This allows for a more targeted and personalized approach to cancer treatment, taking into account the unique characteristics of each patient's cancer. This contrasts with the traditional "one size fits all" approach to cancer treatment, which may result in patients receiving ineffective treatment or causing unnecessary side effects. It has had a significant impact on cancer treatment, especially in the field of oncology. Advances in genomic profiling and other biomarker technologies have made it possible to identify specific genetic mutations and other molecular abnormalities that cause cancer in patients. This knowledge can lead to the development of targeted therapies that can directly address these anomalies, thereby improving treatment outcomes and patients' quality of life.

Advances in Genomic Profiling for Personalized Oncology

Advances in genomic profiling have revolutionized cancer treatment by providing a more personalized approach to patient care. Genomic profiling involves analyzing a patient's DNA to look for genetic mutations and other molecular abnormalities that allow cancer to grow and progress. This information is then used to develop targeted therapies specifically tailored to the unique characteristics of each patient's cancer. Recent advances in genomic profiling technology have enabled the rapid and accurate analysis of large amounts of genomic data. This has enabled the development of new biomarker tests that can identify specific genetic mutations and other molecular abnormalities associated with specific types of cancer. These tests are becoming more sophisticated and can provide more accurate information about a patient's cancer than ever before. As technology continues to advance, it will become an increasingly important tool in the fight against cancer.

Development of New Biomarkers for Cancer Diagnosis and Treatment

Biomarkers are measurable indicators that can be used to detect the presence of a disease or predict its progression. In cancer diagnosis and treatment, biomarkers are important in determining the specific type of cancer and selecting the most appropriate treatment. Advances in biomarker research have resulted in new tools for cancer diagnosis and treatment that can significantly improve patient outcomes. In addition to liquid biopsies, many other novel biomarkers are being developed for cancer diagnosis and treatment. These include genetic and protein markers that can be used to predict which treatment will be most effective for a particular patient and markers that can be used to detect cancer at an earlier, more treatable stage.
Overall, the development of new biomarkers for cancer diagnosis and treatment is an exciting area of research that could significantly improve cancer treatment outcomes.


“Designer babies, the end of diseases, genetically modified humans that never age. Outrageous things that used to be science fiction are suddenly becoming reality. The only thing we know for sure is that things will change irreversibly.”

Event Speakers

Here are some of our speakers

Speaker 1
Speaker 2
Speaker 2
Speaker 2
Speaker 2
Speaker 2

Why Attend


“ As a result of biomedical advances, we are facing the possibility of a future in which our humanity itself will be altered beyond recognition.” - Francis Fukuyama

Comprehensive Agenda

Innovative keynotes delivered by the industry's true heavyweights, covering practical challenges and subjects which are exclusively entailed in our agenda. Gain subject matter expertise, network, and collaborate to explore solutions that shed light on future business models impacting revenue inflows.

Boost your Business

Futurista Start-up Elevate is a dedicated platform for Startups and VCs. We offer industry-specific startups a showcasing opportunity, enabling them to connect with corresponding VCs and Mentors. A win-win dynamic is created to attain the desired exposure for startups who are looking forward to scaling up their businesses.

Intelligent Event Experience

A smart application will help you connect with key decision makers, share files, brainstorm ideas, and have a seamless networking experience. A comprehensive module covering the entire event, compiled for training purposes, to be made available post-conference, exclusively for the attendees.

Who Should Attend


CXO, VP, Director, and Head of -

  • Personalized Medicine
  • Life Sciences Practice
  • Patient Officer
  • Drug Discovery
  • Genome and Gene Sequencing
  • Gene Therapist
  • Clinical Genetic Molecular Biologist Scientist (CGMBS)
  • Bioinformatics
  • Pharmacogenomics
  • Biomarkers
  • Oncologists
  • Liquid Biopsy
  • Data Scientist
  • Radiogenomics
  • Physicians
  • Technology Officer
  • Quality Officer
  • Innovation Officer
  • Executive Officer
  • Physiotherapists
  • Digital Translational Medicine
  • Dermatologist
  • Pathologists
  • Cellular Biomarkers
  • Digital Health
  • Health Economics and Outcomes
  • Clinical Value and Evidence

Topics We Cover

Digital Medicine

Personalized Health Care Technology

Mobile Health (MHealth)

Digital Health

Wearables Technology

Targeted Therapy

Evidence Based Medicine

Precision Oncology

Digital Phenotyping

Genome Targeted Drugs

Computational Genomics

Biochips

Digital Biomarker

Nutrigenomics

Value Based Pricing

Next Gen Sequencing

Microbiomics

DNA Database

CRISPR Cas9

Proteomics

Personalized Medical Devices

Biobanking

Companion Diagnostics

Nanomedicine

Electronic Health Record

Organ On Chip

Telemedicine

DNA Profiling

Predictive Medicine

Preventive Medicine

Personalised Cancer Vaccine

Liquid Biopsy

Early Cancer Detection

MHealth

Digital Pathology

In Vitro Diagnostics

Industries

Biotechnology

Pharmaceuticals

Healthcare

Life Sciences & Biology

Why Sponsor

Why Us

Futurista Startup Elevate

Event Venue

Event venue location info

Join us in San Francisco, United States on the 15th April, 2024